Do BCAAs Reduce Muscle Soreness (DOMS)? What Meta-Analyses Show

Creator: Erin Rose
Published: 2026-07-19

By Erin Rose · Updated July 19, 2026 · Methodology

Educational summary — not medical advice. BCAAs are not a proven recovery cure-all; sleep, progressive training load management, and adequate total protein intake affect recovery far more reliably. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

The honest answer

Real, but modest and timepoint-dependent — not a recovery cure-all. Five meta-analyses and RCTs in this evidence base look at BCAAs and delayed-onset muscle soreness (DOMS) or creatine kinase (a muscle-damage biomarker). Most find some benefit, but the specifics disagree: which timepoint, whether soreness itself or just the biomarker improves, and how much dose and pre-loading matter. The most recent, most granular source (Salem 2024) found soreness reduced at 24-96h but NOT immediately post-exercise — the honest verdict is "real but modest, works best pre-loaded before the damaging exercise," not a blanket claim.

The five trials, read together

BCAA muscle-soreness/muscle-damage evidence in this evidence base
Study	Design	Primary endpoint & result
Salem 2024 PMID 38625669	Meta-analysis + meta-regression, 18 RCTs (13 high quality), search through Sept 2022	DOMS significantly reduced at 24h, 48h, 72h, 96h (all P<0.01) but NOT immediately post-exercise. Creatine kinase reduced immediately and at 72h but not at 24/48/96h. No effect on lactate dehydrogenase at any timepoint. Meta-regression: higher dose and longer pre-supplementation predicted larger benefits. Authors declared no competing interests. Most recent and most granular source — use its time-course specificity, not a blanket claim.
Weber 2021 PMID 34669012	Systematic review + meta-analysis, 10 RCTs (9 meta-analyzed), search through May 2021	7 of 10 studies showed BCAA reduced DOMS at 24-72h; effective doses up to 255mg/kg/day (≈17-18g for a 70kg adult) in trained subjects with mild-to-moderate exercise damage. Authors explicitly state high heterogeneity means efficacy is not established in untrained subjects, when dosed only after damage, or above 255mg/kg/day.
Fedewa 2019 PMID 30938579	Meta-analysis, 8 studies (37 effects, 2007-2017), PRISMA methodology	Primary endpoint (DOMS following acute exercise) MET: large pooled effect (ES=0.729, 95% CI 0.502-0.956, P<0.001) — but on a small total sample (61 participants across the pooled DOMS assessments). A large effect size on a thin evidence base, not definitive.
Rahimi 2017 PMID 28870476	Meta-analysis, 8 trials, search through Nov 2015	Primary endpoint MIXED: creatine kinase significantly reduced at <24h and 24h (P<0.001, P=0.009) — but muscle soreness and lactate dehydrogenase were NOT statistically significant at any follow-up. Authors' conclusion text states a soreness benefit despite the null numeric result — an inconsistency worth flagging; the numeric result is what's reported here.
Shimomura 2010 PMID 20601741	RCT crossover double-blind, n=12 untrained women, 100mg/kg BCAA (1:2.3:1.2 Ile:Leu:Val) BEFORE squats vs. placebo	Primary endpoint (DOMS Days 2-3) MET: soreness significantly lower with BCAA; Day-3 force loss smaller (≈80% of placebo's decline); serum myoglobin rose with exercise in the placebo trial but not the BCAA trial. Small n=12, untrained women only, but the pre-loading design (dosed before the damage) is a pattern repeated across this evidence base.

Consistent thread across all five: creatine kinase (a biomarker) responds more reliably than subjective soreness itself, and dose/timing/pre-loading all affect the result. No trial here claims BCAAs eliminate soreness.

Why creatine kinase and soreness don't always move together

Reading these five sources together, a pattern holds: BCAAs move the biomarker (creatine kinase, a marker of muscle-membrane damage) more consistently than they move how sore you actually feel. Rahimi 2017 is the clearest example — creatine kinase down significantly, soreness not significant, in the same meta-analysis. Salem 2024's more granular time-course data shows why blanket claims fail: CK responds immediately and at 72h, DOMS responds at 24-96h but not immediately — different biomarkers on different clocks, not a single unified "recovery" effect. That's a reason to read soreness claims skeptically when a source only reports the biomarker, or only the timepoint that happened to be positive.

The one-line takeaway BCAAs modestly reduce muscle soreness at specific post-exercise timepoints (Salem 2024: 24-96h, not immediately) and more reliably reduce the creatine-kinase biomarker than soreness itself — real, but inconsistent across meta-analyses and clearly dose/timing-dependent. Pre-loading before the damaging exercise (Shimomura 2010) shows the strongest single-trial signal. See the dosage guide for timing and dose specifics, and best BCAA for cost-effective picks.

Compare BCAA Products

If you're ready to buy, here's how the BCAA products we track and verify compare on cost per gram.

Ranked by cost per day, lowest first — from the Verified Supplement Data catalog, prices reviewed August 2026.
Product	Dose/Serving	Servings	Price	Cost/Day	Certification	Buy
BulkSupplements BCAA 2:1:1 Powder (500 g) Best Value	1000g BCAA	500	$24.97	$0.05	None stated	Buy on Amazon
Nutricost BCAA 1000 mg Capsules (500 ct)	1000mg BCAA	250	$21.95	$0.09	None stated	Buy on Amazon
Optimum Nutrition Mega-Size BCAA 1000 Caps (400 ct)	1000mg BCAA	200	$38.49	$0.19	None stated	Buy on Amazon
Optimum Nutrition Instantized BCAA Powder (5,000 mg/serving, Unflavored)	5000g BCAA	60	$39.99	$0.67	None stated	Buy on Amazon
XTEND Original BCAA Powder, Watermelon Explosion (7,000 mg/serving)	7000g BCAA	30	$24.74	$0.82	None stated	Buy on Amazon

Frequently asked questions